24.69
0.89 (3.74%)
| Previous Close | 23.80 |
| Open | 23.89 |
| Volume | 860,237 |
| Avg. Volume (3M) | 5,375,318 |
| Market Cap | 6,033,500,672 |
| Price / Earnings (TTM) | 224.45 |
| Price / Sales | 6.74 |
| Price / Book | 3.29 |
| 52 Weeks Range | |
| Earnings Date | 28 Oct 2025 |
| Profit Margin | -1.15% |
| Operating Margin (TTM) | 4.31% |
| Diluted EPS (TTM) | -0.050 |
| Quarterly Revenue Growth (YOY) | 4.90% |
| Total Debt/Equity (MRQ) | 46.22% |
| Current Ratio (MRQ) | 2.23 |
| Operating Cash Flow (TTM) | 128.70 M |
| Levered Free Cash Flow (TTM) | 131.69 M |
| Return on Assets (TTM) | 0.99% |
| Return on Equity (TTM) | -0.63% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Specialty Industrial Machinery (US) | Bullish | Bullish |
| Specialty Industrial Machinery (Global) | Bullish | Bullish | |
| Stock | Mirion Technologies, Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 4.0 |
| Insider Activity | -1.5 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | 0.00 |
|
Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Technologies. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Technologies segment is based around the nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. It derives maximum revenue from Technologies Segment. |
|
| Sector | Industrials |
| Industry | Specialty Industrial Machinery |
| Investment Style | Small Core |
| % Held by Insiders | 4.45% |
| % Held by Institutions | 85.66% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Two Creeks Capital Management, Lp | 30 Sep 2025 | 3,598,763 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 35.00 (Citigroup, 41.76%) | Buy |
| Median | 29.00 (17.46%) | |
| Low | 25.00 (Goldman Sachs, 1.26%) | Buy |
| Average | 29.67 (20.17%) | |
| Total | 6 Buy | |
| Avg. Price @ Call | 25.46 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Evercore ISI Group | 25 Nov 2025 | 29.00 (17.46%) | Buy | 25.42 |
| Citigroup | 31 Oct 2025 | 35.00 (41.76%) | Buy | 29.37 |
| 09 Oct 2025 | 28.00 (13.41%) | Buy | 23.39 | |
| JP Morgan | 30 Oct 2025 | 34.00 (37.71%) | Buy | 29.03 |
| 26 Sep 2025 | 28.00 (13.41%) | Buy | 23.76 | |
| Baird | 29 Sep 2025 | 26.00 (5.31%) | Buy | 22.49 |
| Northland Capital Markets | 29 Sep 2025 | 29.00 (17.46%) | Buy | 22.49 |
| Goldman Sachs | 16 Sep 2025 | 25.00 (1.26%) | Buy | 23.94 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| KINGSLEY LAWRENCE D | - | 24.93 | -40,925 | -1,020,260 |
| Aggregate Net Quantity | -40,925 | |||
| Aggregate Net Value ($) | -1,020,260 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 24.93 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| KINGSLEY LAWRENCE D | Director | 24 Nov 2025 | Disposed (-) | 40,925 | 24.93 | 1,020,260 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |